559 related articles for article (PubMed ID: 32723287)
21. Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.
Duran A; Küçükbayrak A; Ocak T; Hakyemez NI; Taþ T; Karadađ M; Mengelođlu ZF
Afr Health Sci; 2013 Jun; 13(2):233-42. PubMed ID: 24235918
[TBL] [Abstract][Full Text] [Related]
22. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever.
Kilinc C; Gückan R; Capraz M; Varol K; Zengin E; Mengeloglu Z; Menekse E
J Vector Borne Dis; 2016; 53(2):162-7. PubMed ID: 27353587
[TBL] [Abstract][Full Text] [Related]
23. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
24. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological characteristics, clinical and laboratory findings supporting preliminary diagnosis of Crimean-Congo hemorrhagic fever in an endemic region in Turkey.
Yeşilbağ Z; Karadeniz A; Koçulu S; Kayhan CB
Wien Klin Wochenschr; 2020 Oct; 132(19-20):581-588. PubMed ID: 32749537
[TBL] [Abstract][Full Text] [Related]
26. Crimean-Congo hemorrhagic fever with hepatic impairment and vaginal hemorrhage: a case report.
Muco E; Como N; Bino S; Harxhi A; Pipero P; Kota M; Mehmeti J; Kushi A; Kraja D
J Med Case Rep; 2018 May; 12(1):118. PubMed ID: 29724249
[TBL] [Abstract][Full Text] [Related]
27. Various clinical conditions can mimic Crimean-Congo hemorrhagic fever in pediatric patients in endemic regions.
Kara SS; Kara D; Fettah A
J Infect Public Health; 2016; 9(5):626-32. PubMed ID: 26868277
[TBL] [Abstract][Full Text] [Related]
28. EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
Vashakidze E; Mikadze I
Georgian Med News; 2015 Oct; (247):54-8. PubMed ID: 26483375
[TBL] [Abstract][Full Text] [Related]
29. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.
Gozdas HT
Afr Health Sci; 2019 Mar; 19(1):1433-1440. PubMed ID: 31148970
[TBL] [Abstract][Full Text] [Related]
31. Crimean Congo Hemorrhagic Fever in Eastern Turkey: Epidemiological and Clinical Evaluation.
Sağmak Tartar A; Balın ŞÖ; Akbulut A; Demirdağ K
Turkiye Parazitol Derg; 2019 Mar; 43(1):26-29. PubMed ID: 30938129
[TBL] [Abstract][Full Text] [Related]
32. [Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever].
Karaşahin Ö; Karaşahin EF
Mikrobiyol Bul; 2021 Jul; 55(3):327-341. PubMed ID: 34416800
[TBL] [Abstract][Full Text] [Related]
33. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India.
Mourya DT; Yadav PD; Gurav YK; Pardeshi PG; Shete AM; Jain R; Raval DD; Upadhyay KJ; Patil DY
BMC Infect Dis; 2019 Feb; 19(1):104. PubMed ID: 30709372
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
35. Bradycardia seen in children with Crimean-Congo hemorrhagic fever.
Oflaz MB; Kucukdurmaz Z; Guven AS; Karapinar H; Kaya A; Sancakdar E; Deveci K; Gul I; Erdem A; Cevit O; Icagasioglu FD
Vector Borne Zoonotic Dis; 2013 Nov; 13(11):807-11. PubMed ID: 24107209
[TBL] [Abstract][Full Text] [Related]
36. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
37. Syndrome of inappropriate antidiuretic hormone associated with Crimean-Congo hemorrhagic fever.
Özer S; Kazancı NÖ; Sönmezgöz E; Karaaslan E; Yılmaz R
Turkiye Parazitol Derg; 2014 Dec; 38(4):275-7. PubMed ID: 25732889
[TBL] [Abstract][Full Text] [Related]
38. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?
Guner R; Hasanoglu I; Tasyaran MA; Yapar D; Keske S; Guven T; Yilmaz GR
Vector Borne Zoonotic Dis; 2014 Aug; 14(8):601-5. PubMed ID: 25072991
[TBL] [Abstract][Full Text] [Related]
39. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
Bajpai S; Nadkar MY
J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children].
Karaaslan E; Çetin Ş
Mikrobiyol Bul; 2021 Apr; 55(2):180-193. PubMed ID: 33882650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
